P103 - Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS

Autor: Ryabov, V., Xu, Q., Schmitt, N., Streuer, A., Ge, G., Bolanos, L., Wunderlich, M., Jann, J.-C., Wein, A., Altrock, E., Mukherjee, S., Ali, A.M., Rapp, F., Nowak, V., Weimer, N., Obländer, J., Palme, I., Göl, M., Jawhar, A., Darwich, A., Wuchter, P., Weiss, C., Raza, A., Foulks, J.M., Starczynowski, D.T., Yang, F.-C., Metzgeroth, G., Steiner, L., Jawhar, M., Hofmann, W.-K., Nowak, D.
Zdroj: In Leukemia Research May 2023 128 Supplement
Databáze: ScienceDirect